Co-founder Dr Robin Smith tells LBB about the research-backed skin and bodycare brand, the deliberate simplicity of the brand’s aesthetic, and how it’s showing up in physical and digital spaces to convey both luxury and efficaciousness.
The skincare market is booming. In 2024, it’s projected to generate revenues of £146.80 billion globally, which is a 3% increase from the previous year – all with a projected growth rate of 0.99% over the next four years. It’s a saturated market too, with global corporations now competing with indie brands and players from the east that, thanks to platforms like TikTok, are creating relevancy faster than ever.
Fuelling this boom is a new kind of skincare obsessive – interested in ingredients, a follower of dermatologists online, and after real results, not unsubstantiated promises. Launching a new skincare brand amid these conditions isn’t easy, yet Exoceuticals® is offering something consumers can’t get elsewhere: exosome-based formulas developed by experienced doctors, backed by years of research.
The science behind exosomes is extensive and complex. Dr Robin Smith, a regenerative medicine specialist and one of the brand’s co-founders, explains it simply: “exosomes help skin cells communicate better with each other, which boosts the skin's natural ability to repair and renew itself”. And who doesn’t want a little help with that?
Exoceuticals® is priced at a premium and sits very much in the luxury category, but it’s the formulas, not the messaging or packaging, which speak for themselves. Staying away from skincare marketing buzzwords and ostentatious branding, Exoceuticals® takes a ‘simplicity with elegance’ approach to how it communicates the science and efficaciousness of the formulas to consumers looking for real results.